Objective:Through analyzing 30 adverse drug reaction (ADR)cases of the Shuxuening injection reported by our hospital from 2011 to 2014, information were collected and analyzed statistically, to comprehend the general pattern and characteristics of induced by Shuxuening injection so as to provide references for using it rationally and securely.Methods:ADR cases by Shuxuening injection reported in the ADR monitoring network databases of Shanxi cardiovascular hospital from Jan.2011 to Dec.2014 were collected, retrospective analysis were performed. Sexuality, age, total usage, the original disease, allergic history, occurrence time of ADR, route of administration, ADRs affected organs and the major clinical manifestations, were classified and analyzed statistically to seek the characteristics and distribution rules of ADR caused by Shuxuening injection.Results:The ADRs caused by Shuxuening injection mainly focuses on skin lesions and systemic damage, including delayed reaction and immediate reaction. The ADR mechanism is connected with drug factors, personal factors and manufacturing technique.Conclusion:More attention should be paid to drug problems found in ADR report, and timely feedback should be performed, such as reasonable choice of solvent and avoid blind combination therapy to reduce or avoid Shuxuening injection related ADR.%目的：通过对2011-2014年度我院30例舒血宁注射液不良反应(adverse reaction，ADR)进行分类统计，从而了解舒血宁注射液ADR发生的特点和规律，并分析导致舒血宁注射液ADR发生的相关因素，以期为舒血宁注射液在临床上的安全、合理使用提供依据。方法：检索全国药品A D R监测网络数据库2011年1月1日-2014年12月31日(以省中心接受日期统计)我院上报的30例舒血宁注射液ADR报告，采用回顾性研究方法，对患者性别、年龄、用法用量、原患疾病、过敏史、ADR发生的时间、给药途径、ADR所累及的器官及主要临床表现等进行分类统计，旨在寻找舒血宁注射液ADR的特征及其分布规律。结果：舒血宁注射液ADR以皮肤损害及全身性损害为主，有迟发型与速发型，其ADR发生机制与药物本身因素及个体差异有关。结论：临床应高度重视舒血宁注射液ADR报告，及时发现问题，如合理选择溶媒，避免盲目联合用药，从而减少或避免舒血宁注射液ADR的发生。
展开▼
